Etofenamate: Difference between revisions
Appearance
Content deleted Content added
Updating {{drugbox}} (changes to watched fields - added verified revid - updated 'ChEMBL_Ref', 'ChEBI_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report errors or [[user talk:CheMoBot|b |
Changing short description from "Chemical compound" to "NSAID analgesic medication" |
||
(31 intermediate revisions by 25 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|NSAID analgesic medication}} |
|||
{{Drugbox |
{{Drugbox |
||
⚫ | |||
| Watchedfields = changed |
|||
⚫ | |||
| IUPAC_name = 2-(2-hydroxyethoxy)ethyl 2-[ [3-(trifluoromethyl)phenyl]amino]benzoate |
| IUPAC_name = 2-(2-hydroxyethoxy)ethyl 2-[ [3-(trifluoromethyl)phenyl]amino]benzoate |
||
| image = Etofenamate.png |
| image = Etofenamate.png |
||
<!--Clinical data--> |
<!--Clinical data--> |
||
| tradename = |
| tradename = |
||
| Drugs.com = {{drugs.com|international|etofenamate}} |
| Drugs.com = {{drugs.com|international|etofenamate}} |
||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
||
| pregnancy_US = <!-- A / B / C / D / X --> |
| pregnancy_US = <!-- A / B / C / D / X --> |
||
| pregnancy_category = |
| pregnancy_category = |
||
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
||
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> |
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> |
||
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> |
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> |
||
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
||
| legal_status = |
| legal_status = OTC |
||
| routes_of_administration = |
| routes_of_administration = Topical (cream, gel, spray) |
||
<!--Pharmacokinetic data--> |
<!--Pharmacokinetic data--> |
||
| bioavailability = |
| bioavailability = |
||
| protein_bound = |
| protein_bound = 98–99% |
||
| metabolism = |
| metabolism = |
||
| metabolites = [[Flufenamic acid]], [[hydroxyl]] derivatives |
|||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
|||
| excretion = 35% [[renal]], mostly [[biliary]] |
|||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number_Ref = {{cascite|correct|??}} |
|||
| CAS_number = 30544-47-9 |
| CAS_number = 30544-47-9 |
||
| ATC_prefix = M02 |
| ATC_prefix = M02 |
||
Line 31: | Line 33: | ||
| PubChem = 35375 |
| PubChem = 35375 |
||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
||
| DrugBank = |
| DrugBank = DB08984 |
||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
| ChemSpiderID = 32560 |
| ChemSpiderID = 32560 |
||
Line 41: | Line 43: | ||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=18 | H=18 | F=3 | N=1 | O=4 |
| C=18 | H=18 | F=3 | N=1 | O=4 |
||
| molecular_weight = 369.33503 g/mol |
|||
| smiles = FC(F)(F)c1cc(ccc1)Nc2ccccc2C(=O)OCCOCCO |
| smiles = FC(F)(F)c1cc(ccc1)Nc2ccccc2C(=O)OCCOCCO |
||
| InChI = 1/C18H18F3NO4/c19-18(20,21)13-4-3-5-14(12-13)22-16-7-2-1-6-15(16)17(24)26-11-10-25-9-8-23/h1-7,12,22-23H,8-11H2 |
|||
| InChIKey = XILVEPYQJIOVNB-UHFFFAOYAL |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C18H18F3NO4/c19-18(20,21)13-4-3-5-14(12-13)22-16-7-2-1-6-15(16)17(24)26-11-10-25-9-8-23/h1-7,12,22-23H,8-11H2 |
| StdInChI = 1S/C18H18F3NO4/c19-18(20,21)13-4-3-5-14(12-13)22-16-7-2-1-6-15(16)17(24)26-11-10-25-9-8-23/h1-7,12,22-23H,8-11H2 |
||
Line 51: | Line 50: | ||
}} |
}} |
||
'''Etofenamate''' is a [[nonsteroidal anti-inflammatory drug]] (NSAID) used for the treatment of joint and muscular [[pain]].<ref>{{cite journal | vauthors = Chlud K | title = [Use of topical non-steroidal anti-inflammatory drugs in aggravated and decompensated arthroses] | language = German | journal = Wiener Medizinische Wochenschrift | volume = 149 | issue = 19–20 | pages = 546–7 | year = 1999 | pmid = 10637963 }}</ref> It is available for topical application as a cream, a gel or as a spray. |
|||
'''Etofenamate''' is a drug used for joint and muscular [[pain]]. |
|||
Etofenamate is acutely toxic if swallowed; it is also very toxic to aquatic life, with long lasting effects.<ref>{{cite web | work = [[PubChem]] | url = https://pubchem.ncbi.nlm.nih.gov/compound/35375 | title = Etofenamate }}</ref>{{Unreliable medical source|date=February 2019}} |
|||
== References == |
|||
{{reflist}} |
|||
{{Anti-inflammatory and antirheumatic products}} |
{{Anti-inflammatory and antirheumatic products}} |
||
{{NSAIDs}} |
|||
{{Topical products for joint and muscular pain}} |
{{Topical products for joint and muscular pain}} |
||
{{Prostanoidergics}} |
|||
[[Category:Nonsteroidal anti-inflammatory drugs]] |
|||
[[Category: |
[[Category:Trifluoromethyl compounds]] |
||
[[Category:Organofluorides]] |
|||
[[Category:Anthranilates]] |
[[Category:Anthranilates]] |
||
[[Category:Ethers]] |
[[Category:Ethers]] |
||
[[Category: |
[[Category:Primary alcohols]] |
||
{{musculoskeletal-drug-stub}} |
{{musculoskeletal-drug-stub}} |
||
[[de:Etofenamat]] |
|||
[[nl:Etofenamaat]] |
|||
[[pl:Etofenamat]] |